特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
962638

世界の左心耳閉鎖市場:2020年~2024年

Global Left Atrial Appendage Closure Market 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
世界の左心耳閉鎖市場:2020年~2024年
出版日: 2020年09月05日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の左心耳閉鎖市場規模は、2020年から2024年の間に16億4000万米ドル成長し、予測期間中は30%のCAGRで成長する見込みです。

市場は、心房細動の発症率増加と、左心耳閉鎖装置の使用における長期的費用対効果に対する期待によって推進されています。

当レポートでは、世界の左心耳閉鎖市場を調査し、市場情勢や規模、ファイブフォース分析、製品別またエンドユーザー別の市場セグメンテーション、顧客や地域別情勢、ベンダー情勢、ベンダー分析などの情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2019年の市場規模
  • 市場の見通し:2019年から2024年の予測

ファイブフォース分析

市場セグメンテーション:製品別

  • 市場セグメンテーション
  • 製品別比較
  • 心外膜左心耳閉鎖装置:市場規模と予測(2019年~2024年)
  • 心内膜左心耳閉鎖装置:市場規模と予測(2019年~2024年)
  • 製品別の市場機会

市場セグメンテーション:エンドユーザー別

顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 欧州:市場規模と予測(2019年~2024年)
  • 北米:市場規模と予測(2019年~2024年)
  • アジア太平洋:市場規模と予測(2019年~2024年)
  • その他の地域:市場規模と予測(2019年~2024年)
  • 主要国
  • 地域別の市場機会
  • ボリューム成長要因-需要主導の成長
  • ボリューム成長要因-外部要因
  • 市場の課題
  • 市場動向

ベンダー情勢

  • ベンダー情勢
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Aegis Medical Group
  • Append Medical
  • AtriCure Inc.
  • Boston Scientific Corp.
  • Cardia Inc.
  • Carestream Health Inc.
  • Johnson & Johnson
  • Lifetech Scientific (Shenzhen) Co. Ltd.
  • Occlutech International AB

付録

目次
Product Code: IRTNTR44439

Technavio has been monitoring the left atrial appendage closure market and it is poised to grow by USD 1.64 bn during 2020-2024, progressing at a CAGR of 30% during the forecast period. Our reports on left atrial appendage closure market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidences of atrial fibrillation and potential long-term cost-effectiveness associated with the use of LAA closure devices. In addition, increasing incidences of atrial fibrillation is anticipated to boost the growth of the market as well.

The left atrial appendage closure market analysis includes the product segment and geographical landscapes.

Technavio's ‘left atrial appendage closure market ’ is segmented as below:

By Product:

  • Epicardial LAA closure device
  • Endocardial LAA closure device

By Geographic Landscape:

  • Europe
  • North America
  • APAC
  • ROW

This study identifies the growing product approvals fueling market growth as one of the prime reasons driving the left atrial appendage closure market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our left atrial appendage closure market covers the following areas:

  • Left atrial appendage closure market sizing
  • Left atrial appendage closure market forecast
  • Left atrial appendage closure market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading left atrial appendage closure market vendors that include Abbott Laboratories, Aegis Medical Group, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Carestream Health Inc., Johnson & Johnson, Lifetech Scientific (Shenzhen) Co. Ltd., and Occlutech International AB. Also, the left atrial appendage closure market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Epicardial LAA closure device - Market size and forecast 2019-2024
  • Endocardial LAA closure device - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by End-user

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume drivers - Demand led growth
  • Volume drivers - External factors
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Aegis Medical Group
  • Append Medical
  • AtriCure Inc.
  • Boston Scientific Corp.
  • Cardia Inc.
  • Carestream Health Inc.
  • Johnson & Johnson
  • Lifetech Scientific (Shenzhen) Co. Ltd.
  • Occlutech International AB

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Product - Market share 2019-2024 (%)
  • 22: Comparison by Product
  • 23: Epicardial LAA closure device - Market size and forecast 2019-2024 ($ million)
  • 24: Epicardial LAA closure device - Year-over-year growth 2019-2024 (%)
  • 25: Endocardial LAA closure device - Market size and forecast 2019-2024 ($ million)
  • 26: Endocardial LAA closure device - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: Europe - Market size and forecast 2019-2024 ($ million)
  • 32: Europe - Year-over-year growth 2019-2024 (%)
  • 33: North America - Market size and forecast 2019-2024 ($ million)
  • 34: North America - Year-over-year growth 2019-2024 (%)
  • 35: APAC - Market size and forecast 2019-2024 ($ million)
  • 36: APAC - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Abbott Laboratories - Overview
  • 48: Abbott Laboratories - Business segments
  • 49: Abbott Laboratories - Key offerings
  • 50: Abbott Laboratories - Key customers
  • 51: Abbott Laboratories - Segment focus
  • 52: Aegis Medical Group - Overview
  • 53: Aegis Medical Group - Product and service
  • 54: Aegis Medical Group - Key offerings
  • 55: Aegis Medical Group - Key customers
  • 56: Aegis Medical Group - Segment focus
  • 57: Append Medical - Overview
  • 58: Append Medical - Product and service
  • 59: Append Medical - Key offerings
  • 60: Append Medical - Key customers
  • 61: Append Medical - Segment focus
  • 62: AtriCure Inc. - Overview
  • 63: AtriCure Inc. - Business segments
  • 64: AtriCure Inc. - Key offerings
  • 65: AtriCure Inc. - Key customers
  • 66: AtriCure Inc. - Segment focus
  • 67: Boston Scientific Corp. - Overview
  • 68: Boston Scientific Corp. - Business segments
  • 69: Boston Scientific Corp. - Key offerings
  • 70: Boston Scientific Corp. - Key customers
  • 71: Boston Scientific Corp. - Segment focus
  • 72: Cardia Inc. - Overview
  • 73: Cardia Inc. - Product and service
  • 74: Cardia Inc. - Key offerings
  • 75: Cardia Inc. - Key customers
  • 76: Cardia Inc. - Segment focus
  • 77: Carestream Health Inc. - Overview
  • 78: Carestream Health Inc. - Product and service
  • 79: Carestream Health Inc. - Key offerings
  • 80: Carestream Health Inc. - Key customers
  • 81: Carestream Health Inc. - Segment focus
  • 82: Johnson & Johnson - Overview
  • 83: Johnson & Johnson - Business segments
  • 84: Johnson & Johnson - Key offerings
  • 85: Johnson & Johnson - Key customers
  • 86: Johnson & Johnson - Segment focus
  • 87: Lifetech Scientific (Shenzhen) Co. Ltd. - Overview
  • 88: Lifetech Scientific (Shenzhen) Co. Ltd. - Business segments
  • 89: Lifetech Scientific (Shenzhen) Co. Ltd. - Key offerings
  • 90: Lifetech Scientific (Shenzhen) Co. Ltd. - Key customers
  • 91: Lifetech Scientific (Shenzhen) Co. Ltd. - Segment focus
  • 92: Occlutech International AB - Overview
  • 93: Occlutech International AB - Product and service
  • 94: Occlutech International AB - Key offerings
  • 95: Occlutech International AB - Key customers
  • 96: Occlutech International AB - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.